488 K. Elberembally
(m, 2 H, SCH2CH2), 3.30–3.50 (br, 1 H, OH), 6.06 (s,1 H, CH), 7.37–7.52 (m, 3 H, ArH), 8.03–
8.06 (m, 2 H, ArH). 13C NMR (75 MHz, CDCl3): δ = 15.0 (SCH3), 21.0, 21.2 (diastereotopic
CH2), 25.3, 29.0, 30.7, 32.5 (CH2), 33.00, 33.4 (diastereotopic CH2), 73.3 (C), 87.7 (OCHS),
=
128.2, I29.5 (CHAR), 129.7 (C), 132.9 (CHAR), 165.6 (C O). Anal. Calcd for C18H26O3S2: C,
60.98%; H, 7.39%; S, 18.08%. Found: C, 60.80%; H, 7.20%; S, 17.60%.
3.2.3. (Rac)-(1-hydroxycyclohexyl)(3-(methylsulfanyl)propylthio)methyl 4-nitrobenzoate (6c)
=
Creamy needles, mp 69–71°C (CH2Cl2/n-pentane). IR (KBr) 3539 (OH), 1716 (C O), 1520,
1348 (NO2), 1268, 1097 (C O) cm−1. 1H NMR (300 MHz, CDCl3): δ = 1.60–1.68 (m, 10 H,
−
(CH2)5), 1.91–1.97 (m, 2 H, CH2CH2CH2), 2.071 (s, 3 H, SCH3), 2.077 (s, 1 H, OH), 2.58
(t, J = 7.2 Hz, 2 H, CH2SCH3), 2.88–2.93 (m, 2 H, SCH2CH2), 6.07 (s, 1 H, CH), 8.23–8.34
(m, AA/BB/system, 4 H, ArH). 13C NMR (75 MHz, CDCl3): δ = 15.2 (SCH3), 21.2, 21.3
(diastereotopic CH2), 25.4, 29.0, 31.1, 32.6 (CH2), 33.2, 33.5 (diastereotopic CH2), 73.4 (C), 89.1
=
(OCHS), 123.5, 130.8 (CHAR), 134.9, 150.6 (C), 164.1 (C O). Anal. Calcd for C18H25NO5S2:
C, 54.11%; H, 6.30%; N, 3.50%; S, 16.04%. Found: C, 54.30%; H, 6.10%; N, 3.80%; S, 16.40%.
3.2.4. (Rac)-2-hydroxy-1-(3-(methylsulfanyl)propylthio)-2,2-diphenylethyl
4-nitrobenzoate (6d)
=
Colorless solid, mp 60–62°C (ether/n-pentane). IR (KBr) 3527 (OH), 1708 (C O), 1523,
1
1346 (NO2), 1269, 1099 (C O) cm−1. H NMR (300 MHz, CDCl3): δ = 1.83–1.90 (m, 2 H,
−
CH2CH2CH2)), 2.00 (s, 3 H, SCH3), 2.46 (t, J = 6.9 Hz, 2 H, CH2SCH3), 2.90–2.96 (m, 2
H, SCH2CH2), 3.65 (br, 1 H, OH), 6.83 (s, 1 H, CH), 7.18–7.69 (m, 10 H, ArH), 7.97–8.16
(AA/BB/system, 4 H, ArH). 13CNMR (75 MHz, CDCl3): δ = 15.3 (SCH3), 28.9, 32.3, 32.6
(CH2), 80.7 (C), 88.7 (OCHS), 123.5 (CHAR), 126.7, 126.8 (diastereotopic CHAR), 127.7, 127.8
(diastereotopic CHAR), 128.0, 128.2 (diastereotopic CHAR), 130.7 (CHAR), 134.5 (C), 142.8,
=
143.0 (diastereotopic C), 150.6 (C), 163.8 (C O). Anal. Calcd for C25H25NO5S2: C, 62.09%;
H, 5.21%; N, 2.89%; S, 13.25%. Found: C, 62.20%; H, 4.90%; N, 2.77%; S, 13.20%.
3.2.5. (Rac)-2-hydroxy-1-(3-(methylsulfanyl)propylthio)-2,2-diphenylethyl benzoate (6e)
=
Colorless solid; mp 104–106°C (CH2Cl2/n-pentane). IR (KBr) 3523 (OH), 1697 ((C O), 1265,
1097 (C O) cm−1. 1H NMR (300 MHz, CDCl3): δ = 1.87–1.94 (m, 2 H, CH2CH2CH2), 2.05
−
(s, 3 H, SCH3), 2.49 (t, J = 7.2 Hz, 2 H, CH2SCH3), 2.91–2.98 (m, 2 H, SCH2CH2), 3.55
(br, 1H, OH), 6.79–6.81 (m, 1 H, CH), 7.21–7.54 (m, 11 H, ArH), 7.73–7.76 (m, 2 H, ArH),
7.91(d,3J = 7.5 Hz, 2 H, ArH). 13C NMR (75 MHz, CDCl3): δ = 15.3 (SCH3), 29.0, 32.3, 32.7
(CH2), 80.6 (C), 87.7 (OCHS), 126.8, 127.0 (diastereotopic CHAr), 127.5, 127.7 (diastereotopic
CHAr), 127.9 (CHAr), I28.1, 128.4 (diastereotopic CHAr), 129.3 (C), 129.6, 133.3 (CHAr), 143.0,
=
143.5 (diastereotopic C), 166.0 (C O). Anal. Calcd for C25H26O3S2: C, 68.46%; H, 5.97%; S,
14.61%. Found: C, 68.90%; H, 5.60%; S, 14.90%.
3.2.6. (Rac)-2-hydroxy-1-(3-(methylsulfanyl)propylthio)-2,2-diphenylethyl
2-phenylacetate (6f)
=
Colorless solid; mp 87–89°C (CH2Cl2/n-pentane). IR (KBr): 3475 (OH), 1716 (C O), 1155,
1
1068 (C O) cm−1. H NMR (300 MHz, CDCl3): δ = 1.79–1.87 (m, 2 H, CH2CH2CH2), 2.06
−
(s, 3 H, SCH3), 2.45 (t, J = 7.2 Hz, 2 H, CH2SCH3), 2.74–2.87 (m, 2 H, SCH2CH2), 3.29 (s, 1
H, OH), 3.50, 3.52 (distorted dd, J = 15.6 Hz, 2 H, diastereotopic CH2Ph), 6.61 (s, 1 H, CH),